Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension
- 1 December 2000
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 140 (6) , 848-856
- https://doi.org/10.1067/mhj.2000.111112
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney diseaseNephrology Dialysis Transplantation, 1999
- Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trialBritish Journal of Clinical Pharmacology, 1999
- Potency of vascular risk factors as the basis for antihypertensive therapyEuropean Heart Journal, 1992
- Left ventricular hypertrophy as a risk factor in arterial hypertensionEuropean Heart Journal, 1992
- Left Ventricular Hypertrophy and Mortality – Results from the Framingham StudyCardiology, 1992
- Left ventricular hypertrophy as a risk factor: the Framingham experienceJournal Of Hypertension, 1991
- Left Ventricular Mass and Incidence of Coronary Heart Disease in an Elderly CohortAnnals of Internal Medicine, 1989
- Electrocardiographic estimate of left ventricular mass versus radiographic cardiac size and the risk of cardiovascular disease mortality in the epidemiologic follow-up study of the first national health and nutrition examination surveyThe American Journal of Cardiology, 1988
- COMPARABILITY OF MORTALITY FOLLOW-UP BEFORE AND AFTER THE NATIONAL DEATH INDEXAmerican Journal of Epidemiology, 1988
- TEST OF THE NATIONAL DEATH INDEXAmerican Journal of Epidemiology, 1984